PMA device
RADIESSE® Injectable Implant
Merz North America, Inc. · Implant, Dermal, For Aesthetic Use (LMH, Class III) · First FDA decision Dec 22, 2006, newest Mar 31, 2026Aesthetic skin, fat and body contouring
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
28
PMA pathway
Device trials
29
Naming "RADIESSE Injectable"
MAUDE reports
676
Brand "RADIESSE Injectable", since 2015
PubMed studies
0
Mentioning "RADIESSE Injectable"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing RADIESSE® Injectable Implant
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 28 decisions filed under this name.
- RADIESSE® Injectable ImplantPMA supplement
P050052-S162 · Decided Mar 31, 2026 · 678 days after receipt · Panel Track
Device type: Implant, dermal, for aesthetic use (LMH) · General & Plastic Surgery
5 more FDA decisions with a free account
Older decisions: P050052-S110, P050052-S096, P050052-S091, P050052-S090, P050052-S081, P050052-S070, P050052-S069, P050052-S031, P050052-S030, P050052-S029, P050052-S027, P050052-S019, P050052, P050037-S129, P050037-S125, P050037-S122, P050037-S110, P050037-S082, P050037-S028, P050037-S027, P050037-S026, P050037-S024
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "RADIESSE Injectable", any status and sponsor, newest update first.
Cutis Medical Laser Clinics Pte LtdNot on our public-company list
NCT05469516 · 13 participants · Start Aug 1, 2022 · Primary completion Aug 15, 2023
Device: Ulthera System [Ulthera, Inc.]; Merz Radiesse Injectable Implant · For: Aging
Sites: Singapore, Singapore
28 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "RADIESSE Injectable", and for the whole product code for context.
This brand
676 reports: 0 malfunction, 676 injury, 0 death
Whole product code LMH
16,542 reports: 1,388 malfunction, 15,105 injury, 12 death
Newest reports for this brand
MW6000674 · Received Aug 7, 2026 · Event dated Jun 30, 2026
Device type: Implant, Dermal, For Aesthetic Use (LMH)
Device problem as coded: Patient-Device Incompatibility
Patient problem as coded: Bacterial Infection; Erythema; Distress; Pharyngitis; Administration Site Reaction; Swelling/ Edema; Abnormal scarring
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2607-2016 · Started May 20, 2016 · Posted by FDA Aug 19, 2016
Reason given: Complaints reported of Radiesse (+) unable to be expelled from the syringe and/or needle.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Implant, Dermal, For Aesthetic Use (LMH)
2 more recall records with a free account
Published research
The most relevant PubMed records for "RADIESSE Injectable"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LMH.
- SculptraQ-Med AB · PMA 2024
- Belotero Balance Dermal FillerMerz North America, Inc. · PMA 2026
- Restylane Injectable GelQ-Med AB · PMA 2022
- Restylane® ContourQ-Med AB · PMA 2026
- Juvederm Voluma XCAllergan · PMA 2025
- Juvéderm Voluma XC, Vollure XC, Volbella XC, Volux XC, SkinviveAllergan · PMA 2026
- Restylane® Lyft with LidocaineQ-Med AB · PMA 2025
- Belotero Balance (+) Lidocaine Dermal FillerMerz North America, Inc. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.